Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mitral Valve Insufficiency | 122 | 2024 | 1414 | 13.530 |
Why?
|
Mitral Valve | 99 | 2025 | 1476 | 7.940 |
Why?
|
Mitral Valve Prolapse | 41 | 2025 | 213 | 7.500 |
Why?
|
Echocardiography, Three-Dimensional | 42 | 2021 | 611 | 3.810 |
Why?
|
Papillary Muscles | 30 | 2023 | 192 | 3.140 |
Why?
|
Ventricular Remodeling | 34 | 2024 | 1273 | 2.480 |
Why?
|
Mitral Valve Stenosis | 13 | 2023 | 343 | 2.110 |
Why?
|
Myocardial Ischemia | 24 | 2021 | 2129 | 1.950 |
Why?
|
Sheep | 35 | 2022 | 1440 | 1.880 |
Why?
|
Echocardiography, Doppler | 26 | 2020 | 899 | 1.650 |
Why?
|
Heart Valve Diseases | 17 | 2024 | 1030 | 1.580 |
Why?
|
Chordae Tendineae | 8 | 2023 | 39 | 1.580 |
Why?
|
Echocardiography | 36 | 2025 | 5044 | 1.490 |
Why?
|
Myocardial Infarction | 33 | 2022 | 11504 | 1.390 |
Why?
|
Mitral Valve Annuloplasty | 9 | 2024 | 145 | 1.260 |
Why?
|
Echocardiography, Doppler, Color | 16 | 2019 | 353 | 1.200 |
Why?
|
Ventricular Dysfunction, Left | 23 | 2020 | 2136 | 1.150 |
Why?
|
Rheumatic Heart Disease | 5 | 2024 | 165 | 1.130 |
Why?
|
Ventricular Function, Left | 30 | 2024 | 3930 | 0.880 |
Why?
|
Aortic Valve Stenosis | 11 | 2023 | 2023 | 0.820 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2019 | 1339 | 0.790 |
Why?
|
Tinnitus | 5 | 2012 | 197 | 0.760 |
Why?
|
Ventricular Function | 2 | 2017 | 403 | 0.720 |
Why?
|
Heart Atria | 11 | 2024 | 1363 | 0.720 |
Why?
|
Tricuspid Valve Insufficiency | 5 | 2023 | 363 | 0.710 |
Why?
|
Aortic Valve | 10 | 2023 | 1968 | 0.670 |
Why?
|
Heart Ventricles | 15 | 2023 | 3831 | 0.660 |
Why?
|
Imaging, Three-Dimensional | 9 | 2017 | 4036 | 0.660 |
Why?
|
Systole | 8 | 2020 | 935 | 0.620 |
Why?
|
Hemodynamics | 16 | 2022 | 4184 | 0.620 |
Why?
|
Fibrosis | 11 | 2023 | 2068 | 0.600 |
Why?
|
Echocardiography, Transesophageal | 8 | 2021 | 1093 | 0.590 |
Why?
|
Adaptation, Physiological | 7 | 2018 | 1308 | 0.580 |
Why?
|
Heart Valve Prosthesis | 8 | 2024 | 1466 | 0.570 |
Why?
|
Heart Valve Prosthesis Implantation | 9 | 2023 | 1566 | 0.560 |
Why?
|
Cardiac Resynchronization Therapy | 3 | 2019 | 562 | 0.560 |
Why?
|
Atrial Function | 1 | 2017 | 98 | 0.560 |
Why?
|
Myocardial Contraction | 11 | 2016 | 1516 | 0.540 |
Why?
|
Hypertension, Pulmonary | 3 | 2022 | 1603 | 0.510 |
Why?
|
Polyvinyl Alcohol | 3 | 2015 | 74 | 0.500 |
Why?
|
Stroke Volume | 24 | 2023 | 5596 | 0.490 |
Why?
|
Calcinosis | 5 | 2024 | 1477 | 0.480 |
Why?
|
Exercise Test | 9 | 2020 | 2180 | 0.470 |
Why?
|
Atrial Fibrillation | 7 | 2023 | 5188 | 0.440 |
Why?
|
Dust | 1 | 2016 | 489 | 0.430 |
Why?
|
Aortic Valve Insufficiency | 6 | 2020 | 575 | 0.430 |
Why?
|
Prolapse | 3 | 2023 | 63 | 0.420 |
Why?
|
Humans | 174 | 2025 | 765734 | 0.420 |
Why?
|
Atrial Function, Left | 4 | 2023 | 189 | 0.420 |
Why?
|
Echocardiography, Doppler, Pulsed | 3 | 2019 | 68 | 0.410 |
Why?
|
Ventricular Function, Right | 5 | 2018 | 629 | 0.410 |
Why?
|
Cardiac Imaging Techniques | 1 | 2015 | 280 | 0.400 |
Why?
|
Myocardial Perfusion Imaging | 5 | 2019 | 669 | 0.390 |
Why?
|
Predictive Value of Tests | 24 | 2023 | 15390 | 0.380 |
Why?
|
Coronary Circulation | 4 | 2016 | 1602 | 0.360 |
Why?
|
Male | 122 | 2025 | 363585 | 0.360 |
Why?
|
Endothelial Cells | 7 | 2022 | 3584 | 0.360 |
Why?
|
Disease Models, Animal | 17 | 2018 | 18289 | 0.350 |
Why?
|
Vascular Resistance | 1 | 2013 | 941 | 0.350 |
Why?
|
Hypertrophy, Left Ventricular | 6 | 2017 | 855 | 0.340 |
Why?
|
Ventricular Dysfunction, Right | 4 | 2023 | 645 | 0.340 |
Why?
|
Heart Failure | 16 | 2023 | 11840 | 0.340 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2010 | 132 | 0.330 |
Why?
|
Magnetic Resonance Imaging, Cine | 5 | 2023 | 1094 | 0.330 |
Why?
|
Models, Cardiovascular | 6 | 2019 | 979 | 0.330 |
Why?
|
Atrial Appendage | 2 | 2023 | 284 | 0.330 |
Why?
|
Severity of Illness Index | 24 | 2023 | 15883 | 0.330 |
Why?
|
Animals | 64 | 2023 | 168731 | 0.320 |
Why?
|
Middle Aged | 84 | 2025 | 222903 | 0.320 |
Why?
|
Female | 113 | 2025 | 395961 | 0.310 |
Why?
|
Aged | 72 | 2025 | 171050 | 0.290 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2019 | 1145 | 0.280 |
Why?
|
Hypertrophy | 2 | 2013 | 561 | 0.280 |
Why?
|
Exercise Tolerance | 4 | 2019 | 841 | 0.260 |
Why?
|
Vestibulocochlear Nerve Diseases | 1 | 2006 | 33 | 0.250 |
Why?
|
Death, Sudden, Cardiac | 2 | 2025 | 1567 | 0.250 |
Why?
|
Genes, Dominant | 2 | 2005 | 855 | 0.250 |
Why?
|
Disease Progression | 11 | 2023 | 13614 | 0.240 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2015 | 3359 | 0.240 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2005 | 191 | 0.240 |
Why?
|
Epithelial-Mesenchymal Transition | 4 | 2022 | 751 | 0.240 |
Why?
|
Heart Valves | 4 | 2019 | 284 | 0.240 |
Why?
|
Endocarditis | 1 | 2009 | 349 | 0.230 |
Why?
|
Extracellular Matrix | 5 | 2020 | 1727 | 0.230 |
Why?
|
Blood Pressure Monitors | 1 | 2004 | 33 | 0.230 |
Why?
|
Nerve Compression Syndromes | 1 | 2006 | 159 | 0.230 |
Why?
|
Cochlear Nerve | 1 | 2006 | 202 | 0.230 |
Why?
|
Losartan | 2 | 2017 | 263 | 0.220 |
Why?
|
Case-Control Studies | 16 | 2025 | 22224 | 0.220 |
Why?
|
Pedigree | 5 | 2025 | 4524 | 0.220 |
Why?
|
Artifacts | 2 | 2020 | 1893 | 0.220 |
Why?
|
Aged, 80 and over | 25 | 2022 | 59459 | 0.210 |
Why?
|
Molecular Biology | 1 | 2007 | 574 | 0.210 |
Why?
|
Oxygen Consumption | 2 | 2020 | 1869 | 0.210 |
Why?
|
Myocardium | 7 | 2022 | 4763 | 0.210 |
Why?
|
Polymers | 3 | 2017 | 1621 | 0.200 |
Why?
|
Sheep, Domestic | 3 | 2017 | 52 | 0.200 |
Why?
|
Cardiac Output | 4 | 2020 | 840 | 0.200 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2004 | 254 | 0.200 |
Why?
|
Rheumatic Fever | 1 | 2022 | 73 | 0.200 |
Why?
|
Thymosin | 1 | 2022 | 47 | 0.190 |
Why?
|
Cell Transdifferentiation | 2 | 2015 | 186 | 0.190 |
Why?
|
Pulmonary Edema | 1 | 2004 | 412 | 0.190 |
Why?
|
Coronary Occlusion | 2 | 2015 | 284 | 0.190 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2010 | 8926 | 0.190 |
Why?
|
Transforming Growth Factor beta | 4 | 2017 | 1994 | 0.190 |
Why?
|
Image Enhancement | 3 | 2007 | 2859 | 0.180 |
Why?
|
Smad3 Protein | 2 | 2018 | 165 | 0.180 |
Why?
|
Treatment Outcome | 19 | 2024 | 65180 | 0.180 |
Why?
|
Heart Septum | 3 | 2010 | 303 | 0.170 |
Why?
|
Adult | 42 | 2025 | 222974 | 0.170 |
Why?
|
Collagen Type I | 2 | 2022 | 616 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 10 | 2020 | 36537 | 0.170 |
Why?
|
Exhalation | 1 | 2020 | 184 | 0.160 |
Why?
|
Lymphatic Vessels | 1 | 2024 | 355 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2018 | 474 | 0.160 |
Why?
|
Aorta, Thoracic | 2 | 2017 | 1103 | 0.160 |
Why?
|
Echocardiography, Stress | 3 | 2016 | 137 | 0.160 |
Why?
|
Contractile Proteins | 2 | 2012 | 240 | 0.160 |
Why?
|
Prognosis | 14 | 2023 | 29899 | 0.150 |
Why?
|
Angioplasty, Balloon | 1 | 2002 | 608 | 0.150 |
Why?
|
Ultrasonography | 10 | 2015 | 5986 | 0.150 |
Why?
|
Time Factors | 16 | 2019 | 40066 | 0.150 |
Why?
|
Arrhythmias, Cardiac | 3 | 2023 | 2249 | 0.150 |
Why?
|
Observer Variation | 8 | 2016 | 2611 | 0.150 |
Why?
|
Stress, Mechanical | 6 | 2019 | 1669 | 0.150 |
Why?
|
Cardiac Surgical Procedures | 2 | 2017 | 3674 | 0.150 |
Why?
|
Estrogen Receptor alpha | 1 | 2022 | 579 | 0.140 |
Why?
|
Follow-Up Studies | 15 | 2021 | 39180 | 0.140 |
Why?
|
Protein Precursors | 1 | 2022 | 1134 | 0.140 |
Why?
|
Oximetry | 1 | 2020 | 459 | 0.140 |
Why?
|
Finite Element Analysis | 1 | 2019 | 441 | 0.140 |
Why?
|
Chromosome Mapping | 1 | 2005 | 4618 | 0.140 |
Why?
|
Organogenesis | 1 | 2018 | 213 | 0.140 |
Why?
|
Surgical Instruments | 1 | 2019 | 379 | 0.140 |
Why?
|
Reproducibility of Results | 16 | 2019 | 20120 | 0.130 |
Why?
|
Elastic Tissue | 1 | 2016 | 65 | 0.130 |
Why?
|
Phenotype | 12 | 2025 | 16706 | 0.130 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2016 | 52 | 0.130 |
Why?
|
Veins | 1 | 2020 | 764 | 0.130 |
Why?
|
Analysis of Variance | 4 | 2017 | 6203 | 0.130 |
Why?
|
Myocarditis | 1 | 2024 | 802 | 0.130 |
Why?
|
Retrospective Studies | 21 | 2023 | 81457 | 0.130 |
Why?
|
Prospective Studies | 15 | 2021 | 54795 | 0.130 |
Why?
|
Collagen | 3 | 2022 | 2618 | 0.130 |
Why?
|
Brazil | 2 | 2017 | 1248 | 0.130 |
Why?
|
Robotics | 1 | 2022 | 808 | 0.130 |
Why?
|
Sarcomeres | 1 | 2018 | 379 | 0.130 |
Why?
|
Auditory Threshold | 3 | 2012 | 369 | 0.120 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2018 | 477 | 0.120 |
Why?
|
Aortography | 1 | 2017 | 414 | 0.120 |
Why?
|
Risk Factors | 18 | 2025 | 74831 | 0.120 |
Why?
|
Risk Assessment | 10 | 2025 | 24279 | 0.120 |
Why?
|
Transducers | 2 | 2008 | 239 | 0.120 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2017 | 429 | 0.120 |
Why?
|
Residence Characteristics | 2 | 2015 | 2115 | 0.120 |
Why?
|
Exercise | 3 | 2017 | 5937 | 0.120 |
Why?
|
Cilia | 1 | 2019 | 499 | 0.120 |
Why?
|
Surgical Mesh | 1 | 2017 | 315 | 0.120 |
Why?
|
Microfilament Proteins | 2 | 2012 | 1130 | 0.120 |
Why?
|
Galectin 3 | 1 | 2016 | 237 | 0.110 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 844 | 0.110 |
Why?
|
Audiometry, Pure-Tone | 2 | 2012 | 210 | 0.110 |
Why?
|
Family | 2 | 2015 | 3207 | 0.110 |
Why?
|
Swine | 7 | 2023 | 5986 | 0.110 |
Why?
|
Bacteroidaceae Infections | 2 | 2004 | 32 | 0.110 |
Why?
|
Heart Aneurysm | 2 | 2005 | 114 | 0.110 |
Why?
|
Inferior Wall Myocardial Infarction | 1 | 2013 | 10 | 0.110 |
Why?
|
Myofibroblasts | 1 | 2015 | 229 | 0.100 |
Why?
|
Bradycardia | 1 | 2014 | 302 | 0.100 |
Why?
|
Injections | 3 | 2015 | 839 | 0.100 |
Why?
|
Coronary Artery Disease | 3 | 2019 | 6545 | 0.100 |
Why?
|
Rupture | 1 | 2014 | 444 | 0.100 |
Why?
|
Organ Size | 3 | 2019 | 2261 | 0.100 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2013 | 139 | 0.100 |
Why?
|
Acoustic Stimulation | 3 | 2012 | 1255 | 0.100 |
Why?
|
Intracranial Embolism | 1 | 2014 | 188 | 0.100 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2013 | 42 | 0.100 |
Why?
|
Pacemaker, Artificial | 2 | 2021 | 827 | 0.100 |
Why?
|
Ventricular Dysfunction | 1 | 2013 | 143 | 0.100 |
Why?
|
Blood Pressure | 4 | 2020 | 8533 | 0.100 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2013 | 276 | 0.100 |
Why?
|
Cardiomyopathies | 3 | 2021 | 2067 | 0.100 |
Why?
|
Cochlear Nucleus | 1 | 2012 | 62 | 0.100 |
Why?
|
Troponin I | 1 | 2016 | 655 | 0.100 |
Why?
|
Myxoma | 1 | 2012 | 114 | 0.090 |
Why?
|
Postoperative Complications | 2 | 2012 | 15749 | 0.090 |
Why?
|
Otoacoustic Emissions, Spontaneous | 1 | 2012 | 139 | 0.090 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 1 | 2011 | 63 | 0.090 |
Why?
|
Heart | 4 | 2019 | 4417 | 0.090 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2012 | 256 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1224 | 0.090 |
Why?
|
Perceptual Distortion | 1 | 2010 | 36 | 0.090 |
Why?
|
Tricuspid Valve | 3 | 2021 | 422 | 0.090 |
Why?
|
Cells, Cultured | 5 | 2022 | 18972 | 0.090 |
Why?
|
Cadherins | 1 | 2015 | 900 | 0.090 |
Why?
|
Matrix Metalloproteinases | 2 | 2016 | 392 | 0.090 |
Why?
|
Blood Flow Velocity | 4 | 2011 | 1381 | 0.090 |
Why?
|
Hyperacusis | 1 | 2010 | 31 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 1514 | 0.090 |
Why?
|
Ventricular Pressure | 3 | 2022 | 210 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6499 | 0.090 |
Why?
|
Ligation | 1 | 2011 | 443 | 0.090 |
Why?
|
Aortic Diseases | 2 | 2014 | 729 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 5 | 2020 | 20667 | 0.080 |
Why?
|
Chi-Square Distribution | 4 | 2013 | 3432 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 5 | 2025 | 18061 | 0.080 |
Why?
|
Models, Animal | 3 | 2011 | 2120 | 0.080 |
Why?
|
Ischemia | 3 | 2022 | 1910 | 0.080 |
Why?
|
Arteriosclerosis | 2 | 2004 | 1053 | 0.080 |
Why?
|
Oxygen | 1 | 2020 | 4242 | 0.080 |
Why?
|
Biopsy | 2 | 2017 | 6754 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2004 | 4528 | 0.080 |
Why?
|
Inferior Colliculi | 1 | 2009 | 79 | 0.080 |
Why?
|
Chronic Disease | 6 | 2013 | 9351 | 0.080 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2015 | 412 | 0.080 |
Why?
|
Pulsatile Flow | 1 | 2009 | 318 | 0.080 |
Why?
|
Mesencephalon | 1 | 2010 | 338 | 0.080 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2012 | 385 | 0.080 |
Why?
|
Cell Proliferation | 4 | 2017 | 10428 | 0.080 |
Why?
|
Diastole | 3 | 2019 | 785 | 0.080 |
Why?
|
Genes, Reporter | 2 | 2010 | 1525 | 0.070 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2010 | 262 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4642 | 0.070 |
Why?
|
Prosthesis Design | 4 | 2019 | 2105 | 0.070 |
Why?
|
Phantoms, Imaging | 2 | 2008 | 2475 | 0.070 |
Why?
|
Equipment Design | 3 | 2017 | 3485 | 0.070 |
Why?
|
Software | 2 | 2015 | 4459 | 0.070 |
Why?
|
Japan | 3 | 2020 | 1415 | 0.070 |
Why?
|
Cell Communication | 1 | 2015 | 1659 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1736 | 0.070 |
Why?
|
Auditory Pathways | 1 | 2009 | 241 | 0.070 |
Why?
|
Heart Rate | 4 | 2012 | 4202 | 0.070 |
Why?
|
Gels | 1 | 2008 | 419 | 0.070 |
Why?
|
Hypertension | 2 | 2004 | 8626 | 0.070 |
Why?
|
Recurrence | 5 | 2021 | 8498 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2936 | 0.070 |
Why?
|
Corpus Callosum | 1 | 2012 | 751 | 0.070 |
Why?
|
Physical Exertion | 1 | 2010 | 665 | 0.070 |
Why?
|
Muscle Cells | 1 | 2008 | 194 | 0.070 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1489 | 0.070 |
Why?
|
Cause of Death | 1 | 2017 | 3709 | 0.070 |
Why?
|
Genetic Research | 1 | 2007 | 173 | 0.060 |
Why?
|
Evoked Potentials, Auditory | 1 | 2009 | 530 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12509 | 0.060 |
Why?
|
Up-Regulation | 2 | 2017 | 4136 | 0.060 |
Why?
|
Myoblasts, Skeletal | 1 | 2006 | 74 | 0.060 |
Why?
|
Cytomegalovirus | 1 | 2010 | 751 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 1166 | 0.060 |
Why?
|
Mutation | 4 | 2018 | 30184 | 0.060 |
Why?
|
Contrast Media | 3 | 2023 | 5326 | 0.060 |
Why?
|
Automation | 1 | 2008 | 585 | 0.060 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2009 | 881 | 0.060 |
Why?
|
Osteoblasts | 1 | 2010 | 1143 | 0.060 |
Why?
|
Gene Transfer Techniques | 1 | 2010 | 1216 | 0.060 |
Why?
|
Dependovirus | 1 | 2010 | 721 | 0.060 |
Why?
|
Carbamazepine | 1 | 2006 | 222 | 0.060 |
Why?
|
Brain | 1 | 2012 | 27178 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2880 | 0.060 |
Why?
|
Mathematical Computing | 1 | 2005 | 143 | 0.060 |
Why?
|
Porphyromonas gingivalis | 2 | 2004 | 165 | 0.060 |
Why?
|
Lod Score | 1 | 2005 | 598 | 0.060 |
Why?
|
Gadolinium DTPA | 1 | 2008 | 822 | 0.060 |
Why?
|
Hydrogels | 1 | 2010 | 728 | 0.060 |
Why?
|
Dilatation, Pathologic | 3 | 2014 | 527 | 0.060 |
Why?
|
Multivariate Analysis | 5 | 2017 | 12056 | 0.060 |
Why?
|
Electrocardiography | 3 | 2012 | 6401 | 0.060 |
Why?
|
Genetic Heterogeneity | 2 | 2005 | 735 | 0.060 |
Why?
|
Sex Factors | 4 | 2023 | 10605 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9337 | 0.060 |
Why?
|
Heredity | 1 | 2025 | 148 | 0.060 |
Why?
|
Sensitivity and Specificity | 7 | 2017 | 14637 | 0.060 |
Why?
|
Cell Transplantation | 1 | 2006 | 473 | 0.060 |
Why?
|
Thalamus | 1 | 2010 | 1048 | 0.060 |
Why?
|
Logistic Models | 4 | 2015 | 13261 | 0.060 |
Why?
|
Statistics, Nonparametric | 3 | 2018 | 2845 | 0.060 |
Why?
|
Recovery of Function | 3 | 2019 | 2965 | 0.060 |
Why?
|
Osteogenesis | 1 | 2010 | 1282 | 0.050 |
Why?
|
Anthropometry | 2 | 2012 | 1339 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2016 | 5125 | 0.050 |
Why?
|
Blood Volume | 1 | 2005 | 542 | 0.050 |
Why?
|
Receptors, Interleukin-1 | 1 | 2004 | 260 | 0.050 |
Why?
|
Heterozygote | 2 | 2018 | 2795 | 0.050 |
Why?
|
Serotonin | 2 | 2022 | 1047 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2007 | 833 | 0.050 |
Why?
|
Rome | 1 | 2022 | 27 | 0.050 |
Why?
|
Illusions | 1 | 2003 | 62 | 0.050 |
Why?
|
Genetic Linkage | 2 | 2005 | 2341 | 0.050 |
Why?
|
Cyproheptadine | 1 | 2022 | 21 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3684 | 0.050 |
Why?
|
Genome-Wide Association Study | 5 | 2022 | 12800 | 0.050 |
Why?
|
Lymphangiogenesis | 1 | 2024 | 171 | 0.050 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2022 | 45 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2017 | 637 | 0.050 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2025 | 582 | 0.050 |
Why?
|
Calcium | 2 | 2022 | 5765 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9594 | 0.050 |
Why?
|
Tachycardia | 1 | 2004 | 594 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2008 | 1273 | 0.050 |
Why?
|
Cohort Studies | 6 | 2018 | 41631 | 0.050 |
Why?
|
Terrorism | 1 | 2004 | 211 | 0.050 |
Why?
|
Coronary Artery Bypass | 3 | 2006 | 2185 | 0.050 |
Why?
|
Decompression, Surgical | 1 | 2006 | 603 | 0.040 |
Why?
|
Infarction | 1 | 2022 | 246 | 0.040 |
Why?
|
Mice, Knockout | 5 | 2019 | 14445 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2004 | 1243 | 0.040 |
Why?
|
Linear Models | 3 | 2017 | 5876 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 452 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1657 | 0.040 |
Why?
|
Apolipoproteins E | 2 | 2004 | 1458 | 0.040 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2010 | 1434 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2011 | 3097 | 0.040 |
Why?
|
Aging | 2 | 2017 | 8730 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12123 | 0.040 |
Why?
|
Endothelium | 1 | 2022 | 768 | 0.040 |
Why?
|
Breath Tests | 1 | 2020 | 297 | 0.040 |
Why?
|
Mice | 9 | 2021 | 81792 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5787 | 0.040 |
Why?
|
Compliance | 1 | 2018 | 100 | 0.040 |
Why?
|
Survival Analysis | 2 | 2016 | 10069 | 0.040 |
Why?
|
Heart Defects, Congenital | 2 | 2012 | 4698 | 0.040 |
Why?
|
Tissue Survival | 1 | 2018 | 121 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11888 | 0.040 |
Why?
|
Gadolinium | 1 | 2023 | 965 | 0.040 |
Why?
|
Proteomics | 2 | 2022 | 3910 | 0.040 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2022 | 825 | 0.040 |
Why?
|
Patient Selection | 2 | 2007 | 4254 | 0.040 |
Why?
|
Heart Function Tests | 1 | 2019 | 317 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2005 | 1456 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2005 | 1535 | 0.040 |
Why?
|
Stem Cells | 1 | 2010 | 3539 | 0.040 |
Why?
|
Prevalence | 4 | 2020 | 15833 | 0.040 |
Why?
|
Cardiac Output, Low | 1 | 2018 | 192 | 0.040 |
Why?
|
Endocardium | 2 | 2012 | 249 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1407 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2004 | 1274 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2008 | 2805 | 0.030 |
Why?
|
Massachusetts | 2 | 2016 | 8876 | 0.030 |
Why?
|
Dietary Fats | 1 | 2004 | 2002 | 0.030 |
Why?
|
Registries | 3 | 2020 | 8293 | 0.030 |
Why?
|
Radiography | 1 | 2007 | 6917 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2022 | 3054 | 0.030 |
Why?
|
Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 1 | 2015 | 6 | 0.030 |
Why?
|
Motion | 2 | 2012 | 781 | 0.030 |
Why?
|
Genetic Markers | 2 | 2018 | 2601 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2022 | 1472 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2016 | 368 | 0.030 |
Why?
|
Zebrafish | 2 | 2019 | 3034 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1364 | 0.030 |
Why?
|
Morphogenesis | 1 | 2019 | 743 | 0.030 |
Why?
|
France | 1 | 2016 | 495 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1788 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1856 | 0.030 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2017 | 462 | 0.030 |
Why?
|
Elastin | 1 | 2016 | 299 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2016 | 2349 | 0.030 |
Why?
|
Random Allocation | 2 | 2012 | 2393 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 627 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2016 | 656 | 0.030 |
Why?
|
New York City | 1 | 2016 | 734 | 0.030 |
Why?
|
Receptors, Angiotensin | 1 | 2014 | 141 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1061 | 0.030 |
Why?
|
Acute Disease | 1 | 2004 | 7232 | 0.030 |
Why?
|
Psychological Techniques | 1 | 2013 | 48 | 0.030 |
Why?
|
Diet, Atherogenic | 2 | 2004 | 91 | 0.030 |
Why?
|
Protein Stability | 1 | 2015 | 577 | 0.030 |
Why?
|
Functional Laterality | 2 | 2010 | 2243 | 0.030 |
Why?
|
Algorithms | 2 | 2020 | 14061 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2017 | 1885 | 0.030 |
Why?
|
Genetic Loci | 1 | 2022 | 2631 | 0.030 |
Why?
|
Endocardial Cushions | 1 | 2012 | 12 | 0.030 |
Why?
|
Thrombosis | 1 | 2006 | 2949 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2023 | 2643 | 0.020 |
Why?
|
Cell Lineage | 2 | 2012 | 2573 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 479 | 0.020 |
Why?
|
Tryptophan Hydroxylase | 1 | 2012 | 93 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3673 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5381 | 0.020 |
Why?
|
Cell Movement | 2 | 2015 | 5192 | 0.020 |
Why?
|
Proteome | 1 | 2022 | 1897 | 0.020 |
Why?
|
New York | 1 | 2014 | 880 | 0.020 |
Why?
|
Signal Transduction | 3 | 2016 | 23589 | 0.020 |
Why?
|
Heart Diseases | 1 | 2004 | 2820 | 0.020 |
Why?
|
Syndrome | 1 | 2018 | 3268 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2002 | 2778 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2021 | 1490 | 0.020 |
Why?
|
Captopril | 1 | 2012 | 261 | 0.020 |
Why?
|
Pulmonary Artery | 1 | 2020 | 1935 | 0.020 |
Why?
|
Transglutaminases | 1 | 2012 | 201 | 0.020 |
Why?
|
Body Patterning | 1 | 2015 | 633 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2015 | 1336 | 0.020 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 326 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2022 | 13403 | 0.020 |
Why?
|
Valine | 1 | 2012 | 410 | 0.020 |
Why?
|
Chick Embryo | 1 | 2012 | 964 | 0.020 |
Why?
|
Osteocalcin | 1 | 2010 | 271 | 0.020 |
Why?
|
Sus scrofa | 1 | 2011 | 430 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2015 | 1865 | 0.020 |
Why?
|
Computational Biology | 1 | 2022 | 3558 | 0.020 |
Why?
|
Stroke | 2 | 2021 | 9747 | 0.020 |
Why?
|
Actins | 1 | 2017 | 2056 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1589 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9299 | 0.020 |
Why?
|
Sound Spectrography | 1 | 2009 | 114 | 0.020 |
Why?
|
Perceptual Masking | 1 | 2009 | 90 | 0.020 |
Why?
|
Chondrogenesis | 1 | 2010 | 238 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2794 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2015 | 1017 | 0.020 |
Why?
|
Mesoderm | 1 | 2012 | 679 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2896 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2263 | 0.020 |
Why?
|
Genotype | 2 | 2018 | 13024 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12402 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2012 | 944 | 0.020 |
Why?
|
Adipogenesis | 1 | 2010 | 370 | 0.020 |
Why?
|
Age Factors | 2 | 2017 | 18375 | 0.020 |
Why?
|
Age Distribution | 1 | 2013 | 2859 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2409 | 0.020 |
Why?
|
Coronary Disease | 1 | 2002 | 5911 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2720 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11007 | 0.020 |
Why?
|
Ventricular Septum | 1 | 2007 | 76 | 0.020 |
Why?
|
Noise | 1 | 2009 | 296 | 0.020 |
Why?
|
Computer Systems | 1 | 2008 | 466 | 0.020 |
Why?
|
Tetrazoles | 1 | 2012 | 920 | 0.020 |
Why?
|
Incidence | 3 | 2014 | 21478 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6252 | 0.020 |
Why?
|
Models, Biological | 1 | 2022 | 9441 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2006 | 281 | 0.020 |
Why?
|
Young Adult | 3 | 2018 | 59852 | 0.010 |
Why?
|
Reference Values | 1 | 2012 | 4909 | 0.010 |
Why?
|
Serum Amyloid A Protein | 1 | 2004 | 127 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6492 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1792 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3618 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12787 | 0.010 |
Why?
|
Postoperative Period | 1 | 2008 | 1816 | 0.010 |
Why?
|
Movement Disorders | 1 | 2007 | 461 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5302 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8279 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2014 | 4494 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 2002 | 181 | 0.010 |
Why?
|
Founder Effect | 1 | 2003 | 185 | 0.010 |
Why?
|
Sinus of Valsalva | 1 | 2002 | 60 | 0.010 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2003 | 140 | 0.010 |
Why?
|
Fibroblasts | 1 | 2012 | 4161 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2005 | 1478 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2002 | 572 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2002 | 26284 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2006 | 2120 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10806 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2002 | 1167 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9647 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12769 | 0.010 |
Why?
|
Acetylcholine | 1 | 2002 | 626 | 0.010 |
Why?
|
Cicatrix | 1 | 2006 | 797 | 0.010 |
Why?
|
Treatment Failure | 1 | 2006 | 2653 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14745 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16041 | 0.010 |
Why?
|
Pericardium | 1 | 2003 | 679 | 0.010 |
Why?
|
Adenoviridae | 1 | 2002 | 1092 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2002 | 988 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2002 | 929 | 0.010 |
Why?
|
Drug Carriers | 1 | 2002 | 700 | 0.010 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2002 | 1043 | 0.010 |
Why?
|
Organ Specificity | 1 | 2002 | 1964 | 0.010 |
Why?
|
Catheterization | 1 | 2002 | 1427 | 0.010 |
Why?
|
Fluorocarbons | 1 | 2002 | 497 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1476 | 0.010 |
Why?
|
Dogs | 1 | 2002 | 3822 | 0.010 |
Why?
|
Haplotypes | 1 | 2003 | 2728 | 0.010 |
Why?
|
Anxiety | 1 | 2010 | 4670 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11641 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2007 | 2788 | 0.010 |
Why?
|
Brain Mapping | 1 | 2009 | 6598 | 0.010 |
Why?
|
Aorta | 1 | 2002 | 2027 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 88781 | 0.010 |
Why?
|
Regression Analysis | 1 | 2003 | 6319 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2002 | 3404 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6061 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12949 | 0.010 |
Why?
|
Depression | 1 | 2010 | 8230 | 0.010 |
Why?
|
Genetic Testing | 1 | 2003 | 3592 | 0.010 |
Why?
|
Gene Expression | 1 | 2002 | 7584 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2003 | 3000 | 0.010 |
Why?
|
Databases, Factual | 1 | 2005 | 8062 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2003 | 2657 | 0.000 |
Why?
|
Rats | 1 | 2002 | 23704 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 22321 | 0.000 |
Why?
|
Child, Preschool | 1 | 2003 | 42468 | 0.000 |
Why?
|
Child | 1 | 2003 | 80499 | 0.000 |
Why?
|